Thursday Cutoff: Post-Thursday Noon - orders ship Monday to ensure temperature control and avoid weekend delays. FREE OVERNIGHT SHIPPING on all orders over $200.

Expected soon: HCG, DSIP, MOTS-c & BPC-157 due soon.

DIY Peptide Nasal Sprays: A Step-by-Step Guide

2 views

Peptide nasal sprays are gaining popularity as a convenient delivery method for these powerful molecules. This guide provides a comprehensive, step-by-step approach to creating your own peptide nasal sprays safely and effectively.

This content is provided exclusively for educational and research purposes. It is not medical advice, does not recommend, endorse, or instruct on human use, consumption, or self-administration of any substances. Peptides such as Semax, Selank, PT-141 (bremelanotide), and Melanotan II are generally unapproved medicines in New Zealand under Medsafe oversight and the Medicines Act 1981 (as amended, including the Medicines Amendment Act 2025).

Many such peptides are not scheduled as prescription medicines but are subject to strict controls on import, possession, and supply when intended for therapeutic use. Medsafe has expressed concerns about unregulated imports, unproven claims, and potential risks, and has considered or pursued classifications to restrict personal imports without prescription. Importing unapproved medicines without proper authorisation (e.g., via section 29 pathways for licensed entities) may be unlawful, and personal importation for therapeutic intent is discouraged due to risks of substandard, contaminated, or counterfeit products.

No approved therapeutic products containing these peptides exist in New Zealand for human use. Always verify current status directly with Medsafe, comply with all laws, and consult qualified professionals or regulatory authorities for legitimate research. The author and this New Zealand-based site accept no liability for misuse of this information. Proceed only in controlled laboratory/research settings with full regulatory compliance.

Peptides are short chains of amino acids studied in research for diverse biological effects, including potential roles in cognitive function, healing, and other areas. Nasal administration is explored in scientific contexts for direct mucosal absorption, potentially bypassing first-pass metabolism and offering rapid onset compared to some other routes.

Why Nasal Delivery is Discussed in Research

  • Potential direct bloodstream access via nasal mucosa

  • Non-invasive convenience in experimental settings

  • Possible improved bioavailability versus oral routes in some studies

This guide combines practical preparation steps with general research considerations, focusing on sterile technique and accurate calculations.

Essential Materials for Laboratory Preparation (Research Only)

  • High-purity peptide powder from reputable sources with third-party Certificates of Analysis (COAs) verifying identity, purity, and concentration

  • Sterile water (preferred for nasal/mucosal research; avoid bacteriostatic agents containing benzyl alcohol, which may cause irritation in mucosal models)

  • 10 mL sterile nasal spray bottle (pharmaceutical-grade, calibrated pump delivering ~0.1 mL per actuation)

  • Sterile syringes, alcohol wipes (70% isopropyl), gloves, and clean workspace

  • Calibrated scale for precise weighing (if reconstituting from powder)

Note: Bacteriostatic saline is sometimes referenced in literature but is unsuitable for nasal research due to potential irritation—use preservative-free sterile water or saline.

Step-by-Step Preparation Method (Laboratory Protocol)

This assumes a sterile environment and proper technique. Total time: 5–15 minutes.

  1. Workspace Preparation Allow peptide vial to reach room temperature. Sanitise all surfaces, vials, and equipment with 70% isopropyl alcohol. Wear gloves. Avoid breathing over open containers.

  2. Reconstitution Slowly add sterile water to the peptide vial (e.g., 2 mL to a 5 mg vial). Inject along the wall to avoid foaming. Gently swirl until fully dissolved—do not shake vigorously, as this may degrade some peptides.

    Example: 5 mg peptide in 2 mL water = 2.5 mg/mL (2500 mcg/mL).

  3. Spray Bottle Assembly Add sterile water to the empty bottle (e.g., 2 mL). Transfer reconstituted solution (e.g., 2 mL) into the bottle. Total: 4 mL in 10 mL bottle.

  4. Sealing & Labelling Secure pump top. Label clearly: peptide name, final concentration, preparation date, storage instructions, and “RESEARCH USE ONLY – REFRIGERATE”.

  5. Storage Refrigerate prepared spray immediately. Store unused powder frozen. Discard if cloudy, discoloured, odorous, or after 30 days.

Dosage & Concentration Calculations (Universal Research Formula)

Standard pump: ~0.1 mL per spray.

Formula: Total peptide (mg) ÷ Total volume (mL) = mg/mL mg/mL × 0.1 = mg per spray (× 1000 = mcg per spray)

Examples (4 mL final volume):

  • 5 mg vial: 5 ÷ 4 = 1.25 mg/mL → 125 mcg/spray

  • 10 mg vial: 10 ÷ 4 = 2.5 mg/mL → 250 mcg/spray

For larger volumes (e.g., 30 mL at 100 mcg/spray target): Total sprays ≈ 300 → Total peptide = 30 mg dissolved in 30 mL.

Research Peptides Commonly Studied Nasally (Examples Only)

Literature and discussions often reference these for nasal exploration:

  • Semax (5 mg vial example) → Final 1.25 mg/mL (125 mcg/spray)

  • Selank (5 mg vial example) → Same as above

  • PT-141 (10 mg vial example) → Final 2.5 mg/mL (250 mcg/spray)

  • Melanotan II (10 mg vial example) → Same as PT-141

Quick Reference Table (4 mL Final Volume Examples)

Peptide

Vial Amount

Final Concentration

mcg per Spray (0.1 mL)

Semax

5 mg

1.25 mg/mL

125 mcg

Selank

5 mg

1.25 mg/mL

125 mcg

PT-141

10 mg

2.5 mg/mL

250 mcg

Melanotan II

10 mg

2.5 mg/mL

250 mcg

Key Research & Safety Considerations

  • Sterility is essential — contamination risks are high without proper technique.

  • Peptide stability — Refrigerate; avoid prolonged room temperature exposure. Make small batches.

  • Quality sourcing — Rely only on suppliers providing verifiable COAs.

  • Irritation indicators — Burning often signals unsuitable solvent (e.g., benzyl alcohol-containing).

  • General precautions — Start low in any experimental model; monitor for changes. Discontinue if issues arise.

Final Reminder Peptide research, especially involving nasal formulations, must adhere strictly to New Zealand regulations. Medsafe continues to monitor unapproved peptides, with potential for further classifications or import restrictions. This guide is educational only—do not interpret as instructions for personal or therapeutic application. For legitimate scientific research, consult institutional review boards, Medsafe guidelines, and legal experts. Stay informed via official sources like Medsafe.govt.nz. Safety and compliance first.